 | | Thursday, May 24, 2012 |  | | | |  |
BioPharma Solutions, a business unit of Baxter, partners with pharmaceutical companies to support their commercialization objectives by providing scientific expertise, sterile manufacturing solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face.
For more information, please visit: http://www.baxterbiopharmasolutions.com. | 
More Top News | 
JAX® Patient-derived Xenograft Resource
The enormous cost, and high failure rate, of cancer drug development have highlighted the need for new preclinical strategies and resources. To this end, a library of more diverse and representative patient-derived tumor xenograft (PDX) models has been created at The Jackson Laboratory. We utilize NOD scid IL2 receptor gamma chain knockout mice ( NSG), constructed by JAX Professor Lenny Shultz, as the mouse host. This PDX resource (which includes tumor gene expression and copy number variation data), developed in collaboration with renowned medical centers throughout the United States, supports large-scale basic and preclinical cancer research and is both affordable and amenable to high throughput studies.
For more information, please visit The Jackson Laboratory . | | 
More Featured News | 
The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic) is designed to bring together all of the major players in the evolving areas of diagnostics. This year, we have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis on applications in the clinic and commercialization. Plan to hear what the industry leaders are saying about future market opportunities and network with your peers this August 21-23 in Washington, DC.
For more information, please visit: www.NextGenerationDx.com. | |  • Biotech Beach (San Diego, California)
Apricus Bio/NexMed
Senior Manager of Regulatory Affairs
Core responsibilities include developing and executing global regulatory CMC strategy. Provides leadership in coordinating and preparing global CMC submissions, change supplements and follow-up to commitments made to various boards of health.
• Genetown (Cambridge, Massachusetts)
Ironwood Pharmaceuticals, Inc.
Manager / Senior Manager, Medical Sciences
Will be a critical individual contributor in a growing Medical Scientific Affairs (MSA) organization. The incumbent will serve a Publications Manager role, responsible for driving pull through of a complex medical communication plan for Ironwood's first product, plus future products, and will also serve as the Grants Coordinator for Investigator-Initiated and Collaborative external research supported by Ironwood.
• BioMidwest (Waukesha, Wisconsin)
Gen-Probe Incorporated
Research Associate II
Responsible for assisting scientific staff in carrying out research assignments involving a variety of laboratory methods, equipment and procedures.
• Rocky Bio (Salt Lake City, Utah)
Watson Pharmaceuticals, Inc.
Scientist Senior
Participates as a team member in method development and validation and complex technical investigation efforts, performs highly technical and specialized Analytical Scientist duties, research on assigned problems and studies in support of Watson's efforts.
• BioTechxus (Houston, Texas)
Pfizer Inc.
Director/Senior Director, Regional Medical & Research Specialist
Responsible for providing clinical and research support for the therapeutic area in the region. The RMRS role is to enhance medical communication between Pfizer and therapeutic experts and researchers, support clinical and outcomes research development, facilitate research site selection and study placement, and assist with the support of both Pfizer sponsored and investigator initiated research activities.
Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center! | | 
Biotech Bay Career Fair
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Bay area.
Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.
Job seekers may register here.
• Biotech Bay Career Fair, Burlingame, CA May 29, 2012
More information about BioSpace's Career Fairs
BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services | | 
Treatment Algorithms: Psoriasis - Prescribing trends mirror guidelines
• Enhance understanding of patient flow and estimate the size of the psoriasis patient pool using interactive country-specific treatment trees.
• Assess the regional dynamics of pharmacological therapy (topical and systemic agents) choice in psoriasis.
• Access a snapshot of current patient-numbers receiving drug therapy at first line and second line and beyond (following first line therapy failure).
Click Here for More Information. | 
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing
This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.
Request Now! | 
Alnylam Pharmaceuticals
300 Third Street
Cambridge, Massachusetts 02142 U.S.A.
Phone: 617-551-8200 Fax: 617-551-8103
Alnylam Pharmaceuticals (NASDAQ: ALNY) is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company is leading the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases, including ALN-TTR for the treatment of transthyretin-mediated amyloidosis (ATTR), ALN-PCS for the treatment of severe hypercholesterolemia, ALN-HPN for the treatment of refractory anemia, and ALN-APC for the treatment of hemophilia.
More Company Profiles | | 
 | FREE Subscription to Life Science Leader
Life Science Leader is designed to not only inform readers of best practices that are occurring throughout the life cycle of the industry, but motivate them to implement those best practices in their own businesses. |
| 
Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship
BioSpace Inc.
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
| BioSpace Inc.
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217 |
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu
BioSpace.com - Life. Science. Community. | | 
• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. | |  | |  |  | |
No comments:
Post a Comment